NRAS and colorectal carcinoma: NRAS‐mutation(+) CRC prognosis remains controversial, since only few studies on its prognosis, analyzing 4–73 cases, have been reported 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33.